Search for Clinical Trial Results
Paraneoplastic Syndromes - 51 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Ephedrine for the Treatment of Congenital Myasthenia Condition: Myasthenic Syndromes, Congenital Date: 2007-10-07 Interventions: Drug: Ephedrine |
Available |
Study Name: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condition:
Date: 2017-02-21 Interventions: Drug: 3,4-Diaminopyridine The investigator will prescribe an initial dose of 3,4 diaminopyridine (DAP) b |
Recruiting |
Study Name: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) Condition: Lambert-Eaton Myasthenic Syndrome Date: 2016-11-16 Interventions:
|
Recruiting |
Study Name: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes Condition: Myasthenic Syndromes, Congenital Date: 2015-09-24 Interventions:
|
Available |
Study Name: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients Condition:
Date: 2013-01-06 Interventions:
|
Available |
Study Name: Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome Condition:
Date: 2011-12-24 Interventions:
|
Completed |
Study Name: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condition: Congenital Myasthenic Syndrome Date: 2011-11-16 |
No longer available |
Study Name: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Date: 2011-06-20 Interventions: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |